Grünenthal is ranked 10th in the multispecialty ranking “Best Pharmaceutical Companies Germany” 2020 in the category “Large Individual, Medium-sized and International Companies”. In Pharma Trend, Grünenthal was awarded for innovation for the first time in 2020 with Palexia®, which received the award “The Most Innovative Product” in the Rx category from pain therapists.
Constipation, stomach pains, and nausea affect patients with opioid-induced constipation (OIC) to such an extent that they can be forced to discontinue treatment. Conventional laxatives are often insufficient. The new PAMORA drug class can help target the adverse intestinal effects of opioids – without negatively affecting central pain inhibition. Naloxegol (MOVENTIG®) is the first of … [Read more…]